For citations:
Vashchenko N.V., Korobkova D.Z., Skorobogatykh K.V., Azimova Yu.E. Efficacy and safety of anti-CGRP(r) monoclonal antibodies in real clinical practice: preliminary analysis after three months of therapy. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(6):62-66. (In Russ.) https://doi.org/10.14412/2074-2711-2021-6-62-66